Duration:5.44
Release date:18/12/2020
Published:18/12/2020
What are the unique challenges involved in developing inhaled generic medicines? Following the US FDA’s approval of VR315 (US), hear from Martin Oliver, our SVP Delivery Management – DPI and pMDI Platforms, as he explains in this podcast.
You can follow our podcast at https://podcast.vectura.com or subscribe it on Spotify, Apple or Google Podcasts.